Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Improved delivery observed for ABL-301 in mouse models of PD

March 15, 2021

Helixmith initiates phase II study of Engensis in ALS

March 15, 2021

E-2027 improves cognitive function in mouse model of AD

March 15, 2021

Chinese researchers disclose SCN10A blockers

March 15, 2021

Takeda compound targets O-GlcNAcase for neurodegenerative disorders

March 12, 2021

Tilavonemab does not show evidence of efficacy in phase II study in progressive supranuclear palsy

March 12, 2021

Placental mesenchymal stem cells studied for in utero repair of myelomeningocele

March 11, 2021

NU-9, the first compound to improve the health of diseased upper motor neurons

March 11, 2021

Maavrx patents TH- and GCH1-encoding genetic constructs for PD

March 11, 2021

Millendo Therapeutics patents tachykinin NK3 receptor antagonists

March 11, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 20, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...